Lung Cancer

Jack A. Roth, MD FACS, Professor and Chairman, Bud Johnson Clinical Distinguished Chair, The University of Texas M.D. Anderson Cancer Center, Department of Thoracic & Cardiovascular Surgery and Professor of Molecular and Cellular Oncology, Director, W.M. Keck Center for Cancer Gene Therapy, Houston, Texas, USA.

1. Markers of Susceptibility; 2. Biology of Preneoplastic Lesions; 3. Familial Predisposition to Lung Cancer; 4. Preoperative Evaluation of the Patient with Lung Cancer; 5. Lung Sparing Operations for Cancer; 6. Role of Thoracoscopy and the Diagnosis and Treatment of Lung Cancer; 7. Surgery for Small-Cell Lung Cancer; 8. Extended Resections for Lung Cancer; 9. High Dose Rate Remote Afterloading Endobronchial Brachytherapy; 10. Three Dimensional Conformal Radiotherapy in Bronchogenic Carcinoma; 11. Combinations of Radiation Therapy and Chemotherapy for NSC Carcinoma of the Lung; 12. Preoperative and Post-Operative Adjunctive Therapy for Resectable NSCLC; 13. New Chemotherapeutic Agents in NSCLC; 14. Chemoprevention; 15. Molecular Detection of Lung Cancer; 16. Fluorescence Detection; 17. Photodynamic Therapy and Thoracic Malignancies; 18. Growth Factor Receptors as a Target for Therapy; 19. Immunological and Biological Approaches to Lung Cancer Therapy; 20. Genetic Manipulations for the Treatment of Lung Cancer